Related Experiment Video
Updated: Jun 22, 2026
07:12
Synthesis and Evaluation of a Ruthenium-based Mitochondrial Calcium Uptake Inhibitor
Published on: October 26, 2017
A novel ruthenium(II) arene based intercalator with potent anticancer activity
José Ruiz1, Consuelo Vicente, Concepción de Haro
1Departamento de Química Inorgánica, Facultad de Química, Universidad de Murcia, 30071, Murcia, Spain. jruiz@um.es
Dalton Transactions (Cambridge, England : 2003)
|June 30, 2009
Summary
A novel ruthenium(II) compound containing 9-aminoacridine demonstrated significant anticancer properties in laboratory tests. This discovery offers potential for new cancer treatment strategies.
Area of Science:
- Organometallic Chemistry
- Medicinal Chemistry
- Cancer Research
Background:
- Ruthenium(II) complexes are explored for their therapeutic potential.
- 9-aminoacridine derivatives exhibit biological activity.
Purpose of the Study:
- To synthesize and evaluate a new ruthenium(II) compound incorporating 9-aminoacridine for anticancer activity.
Main Methods:
- Synthesis of the [(eta6-p-cymene)Ru(N insertion mark C)Cl] complex.
- In vitro assessment of anticancer efficacy.
Main Results:
- The novel ruthenium(II) compound, [(eta6-p-cymene)Ru(N insertion mark C)Cl] (HN insertion mark C=9-aminoacridine), exhibited potent in vitro anticancer activity.
Conclusions:
- The synthesized ruthenium(II) complex shows promise as a potential anticancer agent.
- Further investigation into its mechanism of action and in vivo efficacy is warranted.
More Related Videos
Related Concept Videos
02:34Inhibition of Cdk Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
01:46Electron Transport Chain: Complex I and II
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...